期刊文献+

桑白皮汤治疗泪液分泌不足型干眼症临床观察 被引量:12

Clinical Observation on Sangbaipi Decoction in the Treatment of Dry Eyes of Inadequate Secretion of Tears
下载PDF
导出
摘要 目的观察应用桑白皮汤治疗泪液分泌不足型干眼症的临床疗效。方法将纳入标准的泪液分泌不足型干眼症患者28例52只眼随机分为两组。治疗组14例(26眼)和14例(26眼)。治疗组给予桑白皮汤治疗;对照组给予玻璃酸钠眼水点眼。对比分析两组在眼部症状、角膜荧光素染色、泪液分泌量等方面的疗效。结果在症状疗效方面:对照组有效率为69.2%,治疗组有效率为92.3%,两组有效率比较有显著性差异(P<0.05);在泪液分泌量疗效方面:对照组有效率为46.2%,治疗组有效率为88.5%,两组比较有显著性差异(P<0.05)。结论桑白皮汤治疗泪液分泌不足型干眼症疗效显著,能有效提高患者泪液分泌量,改善干眼症状。 Objective To observe the clinical curative effect of Sangbaipi decoction in the treatment of Dry Eyes of Inadequate Secretion of Tears. Methods 52 eyes of 28 patients with dry eyes met inclusion criteria of inadequate secretion of tears were randomly divided into treatment group( 14 cases,26 eyes) and control group( 14 cases,26 eyes). The treatment group was given Sangbaipi decoction. The control group was given sodium hyaluronate eye drops. Comparative analysis of two groups of efficacy of ocular symptoms,corneal fluorescein staining and tear secretion,etc. Results In the symptoms curative effect,the effective rate was of the control group and the treatment group was 69. 2% and 92. 3%,respectively,and there was significant difference( P 0. 05). In terms of tear secretion curative effect,the effective rate of the control group and the treatment group was 46. 2% and 88. 5%,respectively,and there was significant difference( P 0. 05). Conclusion The Sangbaipi decoction in the treatment of dry eyes of inadequate secretion of tears has obviously therapeutic effect,can effectively improve tear secretion and the symptoms of dry eye.
出处 《光明中医》 2017年第9期1264-1266,共3页 GUANGMING JOURNAL OF CHINESE MEDICINE
基金 河南中医药大学科研苗圃项目(No.MP2015-20)
关键词 桑白皮汤 干眼症 泪液分泌不足 Sangbaipi decoction Dry eyes Inadequate secretion of tears
  • 相关文献

参考文献2

二级参考文献35

  • 1Stem ME,Beuerman RW,Fox RI,et al. The pathology of dry eye:the interaction between the ocular surface and lacrimal glands [ J ].Cornea, 1998,17:584-589.
  • 2Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye[J]. Invest Ophthalmol Vis Sci, 2002,43: 2609-2614.
  • 3Pflugfelder SC. Antiinflammatory therapy for dry eye[J ]. Am J Ophthalmol, 2004,137: 337-342.
  • 4Gao J, Schwalb TA, Addeo JV, et al. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical cyclosporin A therapy[ J ]. Cornea, 1998,17: 654-663.
  • 5Fujihara T, Fujita H, Tsubota K, et al. Preferential localization of CD8^+ alpha E beta 7^+ T cells around acinar epithelial cells with apoptosis in patients with Sjogren' s syndrome[J ]. J Immunol, 1999,163: 2226-2235.
  • 6Pflugfelder SC,Jones D,Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca[J ]. Curr Eye Res, 1999,19:201-211.
  • 7Tsubota K, Fujihara T, Saito K, et al. Conjunctival epithelium expression of HLA-DR in dry eye patients[J]. Ophthalmologica, 1999,213:16-19.
  • 8Pisella PJ, Brignole F, Debbasch C, et al. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca[J ]. Ophthalmology, 2000,107:1841-1849.
  • 9Gao J,Morgan G, Tieu D,et al. ICAM-1 :its role in the pathophysiology of immune activation in the MRL/LPR mouse. Adv Exp Med Bilo, 2002,506: 777-781
  • 10Gao J, Morgan G, Tieu D, et al. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjogrens syndrome-like MRL/lpr mice[J ]. Exp Eye Res, 2004,78:823-835.

共引文献147

同被引文献181

引证文献12

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部